Molecular analysis of JC Polyomavirus genotypes circulating among tribal populations of North-Eastern West Bengal, India

• Autorzy: Chattaraj S. , Bhattacharjee S.
• Języki publikacji: EN

Abstrakty

EN

There is a resurgence of interest in the study of occurrence, genotype and pathogenic associations of human Polyomaviruses in recent years. In the present study, we have ascertained the presence of human Polyomavirus JC (JCV) in the urine and peripheral blood leukocytes of tribal populations, for the first time in the North-Eastern part of West Bengal State of India. We have also characterized the prevalent genotypes of the non-coding control regions (NCCRs) of these natural isolates. The result suggests a high incidence of JCV reactivation in the populations assayed. Approximately 25% of the non-immunocompromized tribal men and women, tested positive based on polymerase chain reaction (PCR) analysis, and these results were further confirmed by sequencing of PCR products. Pairwise sequence comparison and alignment of the NCCR sequence of these Indian strains appeared to be comparable and related to the archetypal JCV (CY) andthe Tibetan LH3 strains, with some alterations in few key positions. The sequence analyses were done with regard to transcription factor binding to DNA sequence elements of endemic JCV NCCRs.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2014
• Tom: 63
• Numer: 2
• Opis fizyczny: p.191-201,fig.,ref.

Twórcy

autor

Chattaraj S.

• Cell and Molecular Biology Laboratory, Department of Zoology, University of North Bengal, Raja Rammohunpur, P.O. NBU, Siliguri, District–Darjeeling, West Bengal, PIN – 734 013, India

autor

Bhattacharjee S.

• Cell and Molecular Biology Laboratory, Department of Zoology, University of North Bengal, Raja Rammohunpur, P.O. NBU, Siliguri, District–Darjeeling, West Bengal, PIN – 734 013, India

Bibliografia

• Agostini H.T., C.F. Ryschkewitsch, R. Mory, E.J. Singer andG.L. Stoner. 1997. JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J. Infect. Dis. 176: 1–8.
• Agostini H.T., R. Yanagihara, V. Davis, C.F. Ryschkewitsch and G.L. Stoner. 1997. Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration. Proc. Natl. Acad. Sci. USA 94: 14542–14546.
• Amemiya K., R. Traub, L. Durham and E.O. Major. 1989. Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J. Biol. Chem. 264: 7025–7032.
• Ariza A., J.L. Mate, A. Fernandez-Vasalo, C. Gomez-Plaza,J. Perez-Piteira, M. Pujol and J.J. Navas-Palacios. 1994. p53 and proliferating cell nuclear antigen expression in JC virus-infected cells of progressive multifocal leukoencephalopathy. Hum. Pathol. 25: 1341–1345.
• Arthur R.R., S. Dagostin and K.V. Shah. 1989. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J. Clin. Microbiol. 27: 1174–1179.
• Baksh F.K., S.D. Finkelstein, P.A. Swalsky, G.L. Stoner,C.F. Ryschkewitsch and P.S. Randhawa. 2001. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am. J. Kidney. Dis. 38: 354–365.
• Boldorini R., E. Omodeo-Zorini, M. Nebuloni, E. Benigni, L. Vago, A. Ferri and G. Monga. 2003. Lytic JC Virus Infection in the Kidneys of AIDS Subjects. Mod. Pathol. 16: 35–42.
• Cartharius K., K. Frech, K. Grote, B. Klocke, M. Haltmeier,A. Klingenhoff, M. Frisch, M. Bayerlein and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinform. 21: 2933–2942.
• Chen N.N. and K. Khalili. 1995. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J. Virol. 69: 5843–5848.
• Chesters P.M., J. Heritage and D.J. McCance. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147: 676–684.
• Chima S.C., C.F. Ryschkewitsch and G.L. Stoner. 1998. Molecular epidemiology of human polyomavirus JC in the Biaka Pygmies and Bantu of Central Africa. Mem. Inst. Oswaldo. Cruz. 93: 615–23.
• Chowdhury M., M. Kundu and K. Khalili. 1993. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene. 8: 887–892.
• Cui X., J.C. Wang, A. Deckhut, B.C. Joseph, P. Eberwein,C.L. Cubitt, C.F. Ryschkewitsch, H.T. Agostini and G.L. Stoner. 2004. Chinese strains (Type 7) of JC virus are afro-asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (Type 2D) and the Korean and Japanese strains (Type 2A). J. Mol. Evol. 58: 568–583.
• Delbue S., E. Branchetti, R. Boldorini, L. Vago, P. Zerbi,C. Veggiani, S. Tremolada and P. Ferrante. 2008. Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals. J. Med. Virol. 80: 2147–2152.
• Devireddy L.R., K.U. Kumar, M.M. Pater and A. Pater. 2000. BAG-1, a novel Bcl-2-interacting protein, activates expression of human JC virus. J. Gen. Virol. 81: 351–357.
• Dorries K., E. Vogel, S. Gunther and S. Czub. 1994. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virol. 198: 59–70.
• Du Pasquier R.A., J.E. Schmitz, J. Jean-Jacques, Y. Zheng,J. Gordon, K. Khalili, N.L. Letvin and I.J. Koralnik. 2004. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J. Virol. 78: 10206–10210.
• Elsner C. and K. Dorries. 1992. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virol. 191: 72–80.
• Frisque R.J., G.L. Bream and M.T. Cannella. 1984. Human polyomavirus JC virus genome. J. Virol. 51: 458–469.
• Gardner S.D., E.F. Mackenzie, C. Smith and A.A. Porter. 1984. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J. Clin. Pathol. 37: 578–586.
• Gasnault J., M. Kahraman, M.G. de Goer de Herve, D. Durali,J.F. Delfraissy and Y. Taoufik. 2003. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 17: 1443–1449.
• Gu Z.Y., Q. Li, Y.L. Si, X. Li, H.J. Hao and H.J. Song. 2003. Prevalence of BK virus and JC virus in peripheral blood leukocytes and normal arterial walls in healthy individuals in China. J. Med. Virol. 70: 600–605.
• Hall T.A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids. Symp. Ser. 41: 95–98.
• Henson J., J. Saffer and H. Furneaux. 1992. The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann. Neurol. 32: 72–77.
• Hou J. and E.O. Major. 2000. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host. J. Neurovirol. 6(Suppl. 2): S98–S100.
• Husseiny M.I., B. Anastasi, J. Singer and S.F. Lacey. 2010. A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. J. Clin. Virol. 49: 137–140.
• Khalili K., J. Gordon and M.K. White. 2006. The polyomavirus, JCV and its involvement in human disease. Adv. Exp. Med. Biol. 577: 274– 287.
• Kitamura T., Y. Aso, N. Kuniyoshi, K. Hara and Y. Yogo. 1990. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J. Infect. Dis. 161: 1128–1133.
• Langer-Gould A., S.W. Atlas, A.J. Green, A.W. Bollen and D. Pelletier. 2009. Progressive multifocal leucoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 361:1075–1080.
• Lonze B.E. and D.D. Guinty. 2002. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 35: 605–623.
• Markowitz R.B., B.A. Eaton, M.F. Kubic, D. Latorra, J.A. McGregor and W.S. Dynan. 1991. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J. Virol. 65: 4515–4519.
• Markowitz R.B., H.C. Thompson, J.F. Mueller, J.A. Cohen and W.S. Dynan. 1993. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and – uninfected subjects. J. Infect. Dis. 167: 13–20.
• Marshall L.J., L. Dunham and E.O. Major. 2010. Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J. Gen. Virol. 9: 3042–3052.
• Monaco M.C., P.N. Jensen, J. Hou, L.C. Durham and E.O. Major. 1998. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J. Virol. 72: 9918–9923.
• Padgett B.L., D.L. Walker, G.M. Zu Rhein, R.J. Echroade and B.H. Dessel. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1: 1257–1260.
• Perez-Liz, G., L. Del Valle, A. Gentilella, S. Croul and K. Khalili. 2008. Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann. Neurol. 64: 379–387.
• Raj G.V. and K. Khalili. 1994. Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol. Cell. Biol. 14: 7770–7781.
• Ranganathan P.N. and K. Khalili. 1993. The transcriptional enhancer element, ϰB, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nuc. Acids. Res. 21: 1959–1964.
• Romagnoli L., I.K. Sariyer, J. Tung, M. Feliciano, B.E. Sawaya,L. Del Valle, P. Ferrante, K. Khalili, M. Safak and M.K. White. 2008. Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virol. 375: 331–341.
• Romagnoli L., H.S. Wollebo, S.L. Deshmane, R. Mukerjee, L. Del Valle, M. Safak, K. Khalili and M.K. White. 2009. Modulation of JC virus transcription by C/EBPbeta. Virus. Res. 146: 97–106.
• Sadowska B., R. Barrucco, K. Khalili and M. Safak. 2003. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J. Virol. 77: 665–672.
• Saruwatari L., H.Y. Zheng, T. Takasaka, C. Sugimoto, E. Sakai,B. Bo, N.N. Aung, T. Kitamura, Y. Yogo and N. Ohno. 2002. Peopling of Myanmar as demonstrated by genotyping of urinary JC virus DNA. Anthropol. Sc. 110: 235–249.
• Staib C., J. Pesch, R. Gerwig, J.K. Gerber, U. Brehm, A. Stangl and F. Grummt. 1996. p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen. Virol. 219:237–246.
• Sugimoto C., M. Hasegawa, H.Y. Zheng, V. Demenev, Y. Sekino, K. Kojima, T. Honjo, H. Kida, T. Hovi, T. Vesikari, J.A. Schalken, K. Tomita, Y. Mitsunobu, H. Ikegaya, N. Kobayashi, T. Kitamura and Y. Yogo. 2002. JC virus strains indigenous to northeastern Siberians and Canadian Inuits are unique but evolutionally related to those distributed throughout Europe and Mediterranean areas.J. Mol. Evol. 55: 322–335.
• Sundsfjord A., A.R. Spein, E. Lucht, T. Flaegstad, O.M. Seterns and T. Traavik. 1994. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J. Clin. Microbiol. 32: 1390–1394.
• Tan C.S., B.J. Dezube, P. Bhargava, P. Autissier, C. Wuthrich,J. Miller and I.J. Koralnik. 2009. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J. Infect. Dis. 199: 881–888.
• Thompson J.D., T.J. Gibson, F. Plewniak, F. Jeanmougin andD.G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nuc. Acids. Res. 25: 4876–4882.
• Wegner M., D.W. Drolet and M.G. Rosenfeld. 1993. Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90: 4743–4747.
• Wollebo H.S., S. Melis, K. Khalili, M. Safak and M.K. White. 2012. Cooperative roles of NF-κB and NFAT4 in Polyomavirus JC regulation at the KB control element. Virol. 432: 146–154.